impact of psychoeducational intervention on patient with inflammatory bowel disease
Phase 2
- Conditions
- inflammatory bowel disease.crohn disease[reginal enteritis]-ulceritive colitisk50- k51
- Registration Number
- IRCT2015041921850N1
- Lead Sponsor
- Vice chancellor for research , Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Willingness to participate in the study; Age over 18 years Patients diagnosed with the disease; Patients in the active phase of the disease Ability to perform physical activity; Not with other chronic illnesses
Exclusion criteria: patient's lack of cooperation during the investigation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physicall symptom. Timepoint: before the intervention and 4 weeks and 8 weeks after intervention. Method of measurement: Crohn's Disease Activity Index,Clinical Scoring System for the CLINICAL colitis Activity Index.;Psychological intervention. Timepoint: befor the intervention,4 weeks after intervention,8 weeks after intervention. Method of measurement: HADS Questionary.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effects of psychoeducational interventions on inflammatory bowel disease (IBD) symptoms?
How does psychoeducational intervention compare to standard-of-care therapies in managing Crohn's disease and ulcerative colitis?
Are there specific biomarkers that predict response to psychoeducational interventions in IBD patients with regional enteritis or ulcerative colitis?
What are the potential adverse events associated with psychoeducational interventions in phase II IBD trials, and how are they managed?
What combination approaches or competitor drugs are being explored alongside psychoeducational interventions for IBD treatment in clinical research?